INTRODUCTION
============

Soft tissue tumors (STTs), putatively mesenchymal origin, are sporadic without a known pathogenesis or established risk factors. There is a rising incidence in recent years for benign soft tissue tumors (BSTTs) more than 300/100,000 and malignant ones around 5/100,000 per year.^[@R1]^ In addition, STTs represent a striking range of morphologic diversity and multiple individual clinical symptoms among different types.^[@R2]^ Differential diagnosis of benign tumors and malignant ones should be made for further treatment in clinic. Soft tissue sarcomas (STSs), as the main malignant tumors, occur at any age and account for only 21% of all pediatric solid malignant cancers and less than 1% of all adult solid malignant cancers.^[@R3]^ It is difficult to make a prospectively preoperative diagnosis of different subtypes of STTs due to their complexity and rarity.

Magnetic resonance imaging (MRI) is considered the first choice of imaging modality to evaluate STTs.^[@R4]^ However, there still are lots of problems need to be dealt with. For example, BSTTs may achieve dedifferentiation and exhibit hybrid histologic characteristics of malignant propensity. In addition, hemangiomas, accounting for 7% of BSTTs,^[@R5]^ show diffuse growth and easy to relapse, which is the main cause of clinical misdiagnosis as malignant tumor. It is reported that MR imaging cannot reliably distinguish benign and malignant lesions when radiologic evaluation is nonspecific.^[@R6]^ The inhomogeneity of lesions on T~2~, the change from homogeneity on T~1~ to inhomogeneity on T~2~ sequence, and the involvement of bone or neurovascular structures are features that may be helpful in differential diagnosing benign from malignant soft tissue masses, while whether MRI can be used to differentiate benign from malignant ones is still controversial.^[@R7]^

Intravoxel incoherent motion (IVIM) imaging is an extension of diffusion weighted imaging (DWI) that integrates the apparent diffusion coefficient (ADC) contains both perfusion and diffusion terms.^[@R8]^ Diffusion and perfusion are physically and biologically different phenomena.^[@R9]^ The diffusion property of tumor tissues largely depends on cell density, which may also be predictive features of malignancy in some types of tumors. Perfusion is an important phenomenon of many physiological or pathological processes.^[@R8]^ It is reported that IVIM imaging may be helpful for differentiating benign and malignant salivary gland tumors.^[@R10]^ Therefore, to estimate these 2 distinctive phenomena in tumor tissues may be helpful in the diagnosis of STTs before surgery.

The purpose of the present study was to assess the IVIM parameters for differential diagnosing hemangiomas, benign soft tissue tumors excluding hemangiomas (BSTTEHs), and STSs.

PATIENTS AND METHODS
====================

Patients
--------

The study was approved by the Institutional Ethics Committee of First Affiliated Hospital of Dalian Medical University (Dalian, China). Thirty-one consecutive patients were enrolled in this study and inspected conventional MR and IVIM-MR examination with 3.0-T MR imager from October 2013 to October 2014. Eight of these patients were excluded for further analysis: 4 patients did not receive surgery and there were no pathological results available; 1 tumor in the upper limb was close to artery and the quality of image was very poor; and for other 3 patients, there were no sufficient regions of interest (ROI) areas for IVIM analysis. As a result, only 23 STTs were further analyzed. Primary sites and clinical data of these tumors (11 female, 12 male; average age, 44 years; age range 16--85 years) were described in Table [1](#T1){ref-type="table"}.

###### 

Primary Sites and Clinical Data of 23 Soft Tissue Tumors
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Conventional MR Imaging
-----------------------

MRI was performed using a 3.0-T MR imager (Signa, HDxt, 3.0 T; General Electric Healthcare, Milwaukee, WI) with surface coil (limbs with 3 inch coil, shoulder with shoulder coil or soft coil, and torso and hips with body coil). The conventional MR scanning sequences included spin echo (SE) T1WI (repetition time/echo time \[TR/TE\], 650 ms/min full; reconstruction matrix size, 288 × 224; slice thickness/slice spacing, 4--6 mm/0--1 mm), fast spin echo (FSE) T~2~WI (TR/TE, 3975 ms/68 ms; number of signals acquired, 4; reconstruction matrix size, 256 × 224; slice thickness/slice spacing, 4--6 mm/0--1 mm), fat suppression T~2~WI and PDWI (TR/TE, 2000 ms/42 ms; number of signals acquired, 3; reconstruction matrix size, 256 × 224; slice thickness/slice spacing, 4--6 mm/0--1 mm). If necessary, fat suppression T~1~WI was performed. Field of view (FOV), which could be changed according to the tumors' size, was 15 to 40 cm with slice thickness 4 to 6 mm and space 0 to 1 mm.

IVIM MR Imaging
---------------

IVIM scan was performed using spin-echo echo-planar imaging (SE-EPI) sequence (TR/TE, 8000 ms/min; NEX, 8; reconstruction matrix size, 128 × 128; slice thickness, slice spacing, and FOV similar to conventional scan; 10 b values \[0, 10, 20, 30, 50, 100, 200, 300, 500, and 800 s/mm^2^\]). In order to eliminate the influence of the anisotropy for the IVIM signal and the numerical measurement, 3 in 1 was applied. All patients were fixed on bed to prevent the influence of movement.

Based on IVIM theory, the bi-exponential model was expressed by the following equation:^[@R11]^ 

where S~b~ is the signal intensity in the pixel with diffusion gradient b, S~0~ the signal intensity in the pixel without diffusion gradient (b of 0 s/mm^2^), f the fractional perfusion related to the microcirculation, ADC~slow~ the true diffusion coefficient as reflected by pure molecular diffusion, and ADC~fast~ is the pseudo-diffusion coefficient representing perfusion-related diffusion or incoherent microcirculation.

Dynamic Contrast-Enhanced MR Imaging
------------------------------------

Dynamic contrast-enhanced MR imaging was performed using 2-dimensional fast spoiled gradient echo sequence (2D FSPGR). The contrast agent gadolinium-DTPA (Magnevist, Berlex, New Jersey) was injected as 0.l mmol/kg, and 2.5 mL/s. And 10 mL saline was additionally injected at the same velocity.

Regions of Interest (ROI)
-------------------------

ROI was placed on the parenchyma of each tumor in DWI. Large cystic or necrotic areas and large vessels were not included. The mean ROI area was about 15.0 ± 1.21 mm^2^. Three ROIs in each image and totally 9 ROIs in 3 consecutive images of IVIM were calculated for each patient. The different values (ADC~standard~, ADC~slow~, ADC~fast~, and f) of STTs were measured in GE-ADW 4.4 workstation.

Statistical Analysis
--------------------

Two independent-sample *t*-test was used for assessing ADC~slow~ and ADC~fast~ of hemangiomas, BSTTEHs, and STSs separately. One-way ANOVA and least significant difference (LSD) *t*-test were used for comparing IVIM parameters among the 3 types of STTs. Receiver operating characteristic (ROC) curves were generated with respective cut-off values determined to accommodate best diagnostic accuracy based on the Youden index. SPSS (version19.0, Chicago, IL) was used for statistical analysis. *P* values \< 0.05 were considered significant for 2-tailed probability.

RESULTS
=======

In total, ROIs from 8 hemangiomas, 11 BSTTEHs, and 4 STSs were evaluated. The mean tumor size (maximum tumor areas measured using axial contrast-enhanced MR images) was 1652.36 ± 233.66 mm^2^. ADC~slow~ and ADC~fast~ value were different among hemangiomas, BSTTEHs, and STSs separately (*P* *\<* 0.001, *P* \< 0.001, and *P* = 0.001).

Each IVIM parameter (ADC~standard~, ADC~slow~, ADC~fast~, and f) for STTs was significant difference (*P* \< 0.001, *P* = 0.001, *P* \< 0.001, and *P* \< 0.001) (Table [2](#T2){ref-type="table"}, Figures [3](#F3){ref-type="fig"}--5). Multiple comparisons of IVIM parameters between each index are summarized in Table [3](#T3){ref-type="table"}. The ADC~standard~, ADC~fast~, and f values of hemangiomas and STSs or BSTTEHs and STSs were significant difference (*P* \< 0.05), while there was no significant difference for these 3 parameters between hemangiomas and BSTTEHs (*P* = 0.584, *P* = 0.907, and *P* = 0.798). The ADC~slow~ values between hemangiomas and BSTTEHs, hemangiomas and STSs, and also BSTTEHs and STSs were significant difference (*P* = 0.014, *P* = 0.036, and *P* \< 0.001).

###### 

One-Way ANOVA Tests Differing IVIM Parameters Among Hemangiomas, BSTTEHs, and STSs
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###### 

LSD *t*-tests of Multiple Comparison of IVIM Parameters Value Among Hemangiomas, BSTTEHs, and STSs
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The ROC curves and optimal cut-off values of IVIM parameters were used to identify STSs from STTs (Figure [1](#F1){ref-type="fig"} and Table [4](#T4){ref-type="table"}). The ADC~slow~ value was the most powerful parameter, with area under the curve of 0.86, followed by ADC~standard~ 0.72 and f 0.56. ADC~fast~ was the least meaningful one with area 0.34. The ROC curve and optimal cut-off value of ADC~slow~ were used to discriminate hemangiomas from BSTTs in Figure [2](#F2){ref-type="fig"} and Table [5](#T5){ref-type="table"}. The optimal cut-off value was between 0.93 × 10^−3^ and 0.96 × 10^−3^ mm^2^/s. Two steps to deal with STTs were indicated in Table [6](#T6){ref-type="table"}. First step was to separate BSTTs (Figures [3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}) from STSs (Figure [5](#F5){ref-type="fig"}), and then to identify hemangiomas (Figure [3](#F3){ref-type="fig"}) from BSTTs.

![ROC curves of IVIM parameters for identifying soft tissue sarcoma from hemangioma and benign tumors.](medi-94-e1028-g005){#F1}

###### 

Diagnostic Characteristics of IVIM Parameters to Identify STSs From STTs Based on the Respective Cut-Off Values
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![ROC curve of ADC~slow~ for discriminating hemangioma from benign tumors.](medi-94-e1028-g007){#F2}

###### 

Diagnostic Characteristics of ADC~slow~ to Discriminate Hemangiomas from BSTTs Based on the Respective Cut-Off Values
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###### 

Two Steps to Deal with STTs: Firstly, Differentiating BSTTs and STSs, and Then Identifying Hemangiomas From BSTTs
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![A 23-year-old female was diagnosed hemangioma (arrow) in the right brachialis. (A) Axial T~1~WI demonstrates a solid mass of intermediate signal intensity (SI) compared to adjacent muscles. (B) Axial T~2~WI shows a lobulated mass with high SI. (C) Contrast-enhanced T~1~WI image shows intense homogeneous enhancement with large internal vessels. Characteristic changes in intravoxel incoherent motion (IVIM) parameters: (D) Location maps of ROI~1~, ROI~2~, and ROI~3~ in the first sectional image. Images (E--H) show ADC~standard~, ADC~slow~, ADC~fast~, and f value separately. (I) Location maps of ROI~4~, ROI~5~, and ROI~6~ in the second sectional image. ADC~standard~, ADC~slow~, ADC~fast~, and f value were placed in (J--M) successively. (N) Location maps of ROI~7~, ROI~8~, and ROI~9~ in the third sectional image. ADC~standard~, ADC~slow~, ADC~fast~, and f value were put in (O--R) in proper order. Mean value of ADC~standard~ is 0.00160 ± 0.000288 mm^2^/s, ADC~slow~ 0.000943 ± 0.000448 mm^2^/s, ADC~fast~ 0.0111 ± 0.00319 mm^2^/s, and f 0.725 ± 0.0827 from ROI~1~ to ROI~9~, accordingly.](medi-94-e1028-g010){#F3}

![A 59-year-old male was diagnosed Schwannoma (arrow) in the subcutaneous fat of left knee between vastus medialis and sartorius. (A) Axial T~1~WI demonstrates a solid mass of intermediate signal intensity (SI). (B) Axial T~2~WI shows the ovoid mass with heterogeneously hyper SI. (C) Contrast-enhanced T~1~WI shows heterogeneously enhanced. Characteristic changes in IVIM parameters: (D) Location map of ROI~1~, ROI~2~, and ROI~3~ in the first sectional image. Images (E--H) separately show ADC~standard~, ADC~slow~, ADC~fast~, and f value. (I) Location map of ROI~4~, ROI~5~, and ROI~6~ in the second sectional image. ADC~standard~, ADC~slow~, ADC~fast~, and f value were placed in (J--M) successively. (N) Location maps of ROI~7~, ROI~8~, and ROI~9~ in the third sectional image. ADC~standard~, ADC~slow~, ADC~fast~, and f value were put in (O--R) in proper order. Mean value of ADC~standard~ is 0.00168 ± 0.000129 mm^2^/s, ADC~slow~ 0.00130 ± 0.000140 mm^2^/s, ADC~fast~ 0.0108 ± 0.000380 mm^2^/s, and f 0.714 ± 0.0307 from ROI~1~ to ROI~9~, accordingly.](medi-94-e1028-g011){#F4}

![A 74-year-old female was diagnosed myxoid liposarcoma (arrow) in the subcutaneous fat of her right back. (A) Axial T~1~WI demonstrates a solid mass of low signal intensity (SI). (B) Axial T~2~WI shows a lobulated mass with high SI. (C) Contrast-enhanced T~1~WI shows heterogeneously enhanced solid tissues and thickened septa. Characteristic changes in IVIM parameters: (D) Location maps of ROI~1~, ROI~2~, and ROI~3~ in the first sectional image. Images (E--H) separately show ADC~standard~, ADC~slow~, ADC~fast~, and f value. (I) Location maps of ROI~4~, ROI~5~, and ROI~6~ in the second sectional image. ADC~standard~, ADC~slow~, ADC~fast~, and f value were placed in (J--M) successively. (N) Location maps of ROI~7~, ROI~8~, and ROI~9~ in the third sectional image. ADC~standard~, ADC~slow~, ADC~fast~, and f value were put in (O--R) in proper order. Mean value of ADC~standard~ is 0.00118 ± 0.000134 mm^2^/s, ADC~slow~ 0.000849 ± 0.000207 mm^2^/s, ADC~fast~ 0.0140 ± 0.00344 mm^2^/s, and f 0.562 ± 0.0631 from ROI~1~ to ROI~9~, accordingly.](medi-94-e1028-g012){#F5}

DISCUSSION
==========

There are similar imaging characteristics (such as diffuse growth, easy to relapse, and high signal intensity on T~2~-weighted imaging/DW-MRI) for hemangiomas and malignant tumors. This is the main reason for radiological and clinical misdiagnosing hemangiomas as malignant tumors. So hemangiomas were classified out as a separate group in this study.

IVIM MR imaging has been utilized as an attractive noninvasive imaging technique with the potential for assessing both tissue perfusion and diffusion of STTs using a single DW imaging.^[@R10],[@R12]^ And it shows a unique profile of microcirculation and pure molecular diffusion within tumors. Our study showed that the ADC~slow~ and ADC~fast~ values of hemangiomas, BSTTEHs, and STSs were significantly different, which suggested that IVIM imaging facilitates understanding of tumor tissue characteristics of perfusion and diffusion.

On the other hand, ADC~standard~ values of hemangiomas, BSTTEHs, and STSs were also significantly different. The ADC~standard~ of BSTTEHs was maximum (1.555 ± 0.176 × 10^−3^ mm^2^/s), while the ADC~standard~ of STSs was minimum (1.009 ± 0.177 × 10^−3^ mm^2^/s) due to active proliferative capacity of sarcomas. The limitation of water molecular diffusion of malignant tumors leads to the decrease of ADC value.^[@R13]^

In the bi-exponential model, ADC~slow~ (*P* = 0.014) was an effective parameter to distinguish hemangiomas from other benign tumors. ADC~slow~ with a high b value (\>200 s/mm^2^) is the true diffusion coefficient of pure water in tumors with perfusion components removed at the same time. There were significant differences for values of ADC~slow~ among hemangiomas, BSTTEHs, and STSs (Table [3](#T3){ref-type="table"}). The value of ADC~slow~ decreased from BSTTEHs to STSs with hemangiomas in the middle level. The reason is that potential proliferation of STSs is faster than BSTTs. For STSs, there are large nuclei, less cytoplasm, and a dense array of cells, which lead to the extracellular space reduced, the cell membrane permeability reduced, and the water molecular diffusion limited.^[@R14]--[@R17]^ So ADC~slow~ decreased significantly. According to ROC curve, the cut-off value of ADC~slow~ without perfusion effects is smaller than that of ADC~standard~ in the bi-exponential of IVIM model. As stated above, ADC~slow~ may be a meaningful parameter for differential diagnosis of hemangiomas, BSTTEHs, and STSs.

Microcirculation perfusion, namely fast moving component in the bi-exponential of IVIM model, is more sensitive to the MR signal attenuation.^[@R18]^ According to the bi-exponential theory, ADC~fast~ is closely related to microvessel density of tumor tissues at low b value (\<200 s/mm^2^). In this study, ADC~fast~ was significantly greater than related ADC~slow~. It means that ADC~fast~ is sensitive to MR signal attenuation at lower b values. There is a maximum value of ADC~fast~ of STSs as the same results of report^[@R12]^ about ADC~fast~ for different groups (cervical tumor, myometrium, and leiomyoma), which confirmed ADC~fast~ associated with the degree of tissue microvessel perfusion.

The fractional volume of capillary blood flowing in each voxel is measured using f.^[@R19]^ f value may correlate with the amount of normal angiogenesis with intact vessels in terms of basement membrane thickness and pericyte coverage, and it increases with the augmented tissue perfusion components.^[@R20]^ Our results suggest that hemangiomas (0.682 ± 0.060) are rich in capillaries per unit tumor volume, while STSs (0.503 ± 0.068) are relatively poor in capillaries because liposarcomas and extraskeletal myxoid chondrosarcomas are not rich in blood vessels. Therefore, f value may be an indicator of intact vascular permeability.

There are several limitations in this research. First of all, a major limitation of the present study was the small patient cohort of different STTs. Furthermore, IVIM imaging is sensitive to little movement, which may be problematic for thigh IVIM imaging due to pulsation of arteries. Lastly, this study was only to screen out hemangioma from BSTTs, and further research is necessary to differentiate other types of STTs.

CONCLUSION
==========

To our knowledge, this is the first of its kind report about the application of pixel-based IVIM imaging to evaluate heterogeneous STTs. It may provide useful information to discriminate malignant tumors from benign ones regarding patient stratification and strategy in further treatment.

Abbreviations: ADC = apparent diffusion coefficient, BSTTEHs = benign soft tissue tumors excluding hemangiomas, BSTTs = benign soft tissue tumors, DWI = diffusion weighted imaging, MRI = magnetic resonance imaging, STSs = soft tissue sarcomas, STTs = soft tissue tumors.
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